============================================================
KAIROS ML PROTOTYPE V0 - DIFFERENTIAL EXPRESSION REPORT
Dataset: GSE114007 (Knee Cartilage OA vs Control)
Generated: 2025-12-26 19:14:45
============================================================

ANALYSIS PARAMETERS
----------------------------------------
Statistical test: Welch's t-test
Multiple testing correction: Benjamini-Hochberg FDR
Significance threshold: FDR < 0.05, |log2FC| > 1
OA samples: 20
Control samples: 18

RESULTS SUMMARY
----------------------------------------
Total genes tested: 23,710
Significant genes (FDR < 0.05): 3,270
Significant genes (FDR < 0.05, |log2FC| > 1): 1,269
  - Upregulated in OA: 642
  - Downregulated in OA: 627

TOP 10 UPREGULATED IN OA
----------------------------------------
  POSTN: log2FC = 5.92, FDR = 1.67e-07
  COL1A1: log2FC = 5.17, FDR = 5.93e-07
  TNFAIP6: log2FC = 4.09, FDR = 2.42e-06
  LRRC15: log2FC = 4.04, FDR = 2.10e-07
  TGFBI: log2FC = 4.02, FDR = 6.94e-06
  THY1: log2FC = 3.94, FDR = 3.55e-07
  TNC: log2FC = 3.73, FDR = 1.34e-04
  CHI3L2: log2FC = 3.66, FDR = 3.56e-04
  GRIA2: log2FC = 3.57, FDR = 5.47e-08
  CFI: log2FC = 3.53, FDR = 7.70e-10

TOP 10 DOWNREGULATED IN OA
----------------------------------------
  ADM: log2FC = -4.58, FDR = 2.00e-09
  DDIT4: log2FC = -4.06, FDR = 2.13e-08
  HILPDA: log2FC = -3.77, FDR = 1.90e-09
  ATF3: log2FC = -3.60, FDR = 3.62e-09
  LOC143666: log2FC = -3.15, FDR = 3.62e-09
  CISH: log2FC = -3.15, FDR = 3.06e-09
  MAFF: log2FC = -3.13, FDR = 9.39e-14
  FOSB: log2FC = -3.12, FDR = 7.41e-04
  SIK1: log2FC = -3.11, FDR = 4.05e-06
  JUN: log2FC = -3.06, FDR = 2.48e-08

OUTPUT FILES
----------------------------------------
  GSE114007_diff_expr_results.csv
  GSE114007_significant_genes.csv
  GSE114007_ranked_genes.csv
  GSE114007_upregulated_in_OA.csv
  GSE114007_downregulated_in_OA.csv
  volcano_plot.png
  top_genes_heatmap.png

NEXT STEPS
----------------------------------------
  1. Pathway enrichment analysis (MSigDB Hallmarks)
  2. Intersection with aging gene signatures
  3. Filter for secreted factors (MSC-deliverable)
  4. Prioritize therapeutic candidates

============================================================